ArthroCare's Quiet Stock Ride
This article was originally published in Start Up
Executive Summary
ArthroCare's stock is soaring. Following a series of favorable announcements by the company, its price has risen steadily over the past several months, reaching a high of $72.50 on October 29. Arthrocare's most important announcement concerned the settlement of its patent litigation with Johnson & Johnson.